Spyre Therapeutics, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: SYRE
Spyre Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker SYRE. It has reported private securities offerings to the US SEC, most recently $180 million sold in a notice filed in 2023.
Spyre Therapeutics at a glance
What does Spyre Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $180 million sold (2023).
Frequently asked questions about Spyre Therapeutics
Where is Spyre Therapeutics headquartered?
Spyre Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Spyre Therapeutics do?
Spyre Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Spyre Therapeutics a public company?
Yes. Spyre Therapeutics, Inc. trades on Nasdaq under the ticker SYRE.
When was Spyre Therapeutics founded?
The earliest incorporation on record for Spyre Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
- Werewolf Therapeutics, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.